STOCK-BASED COMPENSATION (Tables)
|
3 Months Ended |
Mar. 31, 2022 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of time based stock option |
Schedule of time based stock option
| |
|
March 31, |
|
| |
|
2022 |
|
2021 |
|
| |
|
|
|
|
|
|
|
| Dividend yield |
|
|
0.00% |
|
|
0.00% |
|
| Expected Volatility |
|
|
76.1 – 77.5% |
|
|
74.01 – 74.28% |
|
| Weighted-average volatility |
|
|
— |
|
|
— |
|
| Expected dividends |
|
|
— |
|
|
— |
|
| Expected term (in years) |
|
|
10 |
|
|
10 |
|
| Risk-free rate |
|
|
1.81 – 1.87% |
|
|
1.20 – 1.62% |
|
|
| Schedule of stock option plan |
The following table summarizes the status of the 2015 Plan with respect
to time based stock options:
Schedule of stock option plan
| |
|
Three Months Ended March 31, |
|
| |
|
2022 |
|
2021 |
|
| |
|
Shares |
|
Weighted
Average
Exercise
Price |
|
Shares |
|
Weighted
Average
Exercise
Price |
|
| |
|
|
|
|
|
|
|
|
|
| Outstanding at January 1 |
|
3,672,500 |
|
$ |
3.42 |
|
2,922,494 |
|
$ |
2.46 |
|
| Granted |
|
135,000 |
|
$ |
3.07 |
|
1,250,000 |
|
$ |
3.94 |
|
| Exercised |
|
75,000 |
|
$ |
1.60 |
|
1,000,000 |
|
$ |
1.23 |
|
| Forfeited |
|
93,750 |
|
$ |
1.57 |
|
— |
|
$ |
— |
|
| Outstanding at March 31 |
|
3,638,750 |
|
$ |
3.49 |
|
3,172,494 |
|
$ |
3.43 |
|
| Options exercisable at March 31 |
|
1,358,750 |
|
$ |
2.83 |
|
803,119 |
|
$ |
2.09 |
|
| Weighted average fair value of options granted during the period |
|
— |
|
$ |
2.45 |
|
— |
|
$ |
3.06 |
|
| Stock-based compensation expense |
|
— |
|
$ |
524,670 |
|
— |
|
$ |
1,086,681 |
|
|
| Schedule of information pertaining to options outstanding |
The following table presents information pertaining to options outstanding
at March 31, 2022:
Schedule of information pertaining to options outstanding
| Range of Exercise Price |
|
Number
Outstanding |
|
Weighted
Average
Remaining
Contractual
Life |
|
Weighted
Average
Exercise
Price |
|
Number
Exercisable |
|
Weighted
Average
Exercise
Price |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $1.57-$9.76 |
|
3,638,750 |
|
8.5 years |
|
$ |
3.49 |
|
1,358,750 |
|
$ |
2.83 |
|
|
| Schedule of performance base options outstanding |
The following table summarizes the status of the 2015 Plan with respect
to performance-based stock options:
Schedule of performance base options outstanding
| |
|
Three Months Ended March 31, |
|
| |
|
2022 |
|
2021 |
|
| |
|
Shares |
|
Weighted
Average
Exercise
Price |
|
Shares |
|
Weighted
Average
Exercise
Price |
|
| |
|
|
|
|
|
|
|
|
|
| Outstanding at January 1 |
|
— |
|
$ |
— |
|
1,000,000 |
|
$ |
1.70 |
|
| Granted |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Exercised |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Forfeited |
|
— |
|
$ |
— |
|
1,000,000 |
|
$ |
1.70 |
|
| Outstanding at March 31 |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Options exercisable at March 31 |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Weighted average fair value of options granted during the period |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Stock-based compensation expense |
|
— |
|
$ |
— |
|
— |
|
$ |
(408,747 |
) |
|
| Schedule of activities for our unvested restricted stock awards |
Schedule of activities for our unvested
restricted stock awards
| |
|
Three Months Ended March 31, |
|
| |
|
2022 |
|
2021 |
|
| |
|
Shares |
|
Weighted
Average
Grant-Date Fair Value |
|
Shares |
|
Weighted
Average
Grant-Date Fair Value |
|
| |
|
|
|
|
|
|
|
|
|
| Unvested at January 1 |
|
1,000,000 |
|
$ |
3.01 |
|
— |
|
$ |
— |
|
| Granted |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Vested |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Forfeited/canceled |
|
— |
|
$ |
— |
|
— |
|
$ |
— |
|
| Unvested at March 31 |
|
1,000,000 |
|
$ |
3.01 |
|
— |
|
$ |
— |
|
|
| Schedule of restricted stock units |
Schedule
of restricted stock units
| Range of Exercise Price |
|
Number
Outstanding |
|
Weighted
Average
Remaining
Contractual
Life |
|
Weighted
Average
Exercise
Price |
|
Number
Exercisable |
|
Weighted
Average
Exercise
Price |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $3.31 |
|
1,000,000 |
|
3.20 years |
|
$ |
3.01 |
|
— |
|
$ |
3.01 |
|
|